Today, we had a correspondence published in Nature Biotechnology about "Industrializing rare disease therapy discovery and development". We hope this will spark discussion on how such treatments can be developed cost effectively and how in the future we can attempt to bring the costs for rare disease treatment development even lower so that many more diseases can be addressed.